Nanoparticles have once again reached the spotlight, this time as a critical tool to combat the spread of covid-19. In this ...

In this Thought Leader article., Ian Johnston from Cytiva discusses challenges related to process development, scaling technology, regulatory approvals, and GMP guidelines.

A new framework bridges a gap in understanding RNA therapeutics by linking the structure of lipid nanoparticles to immune ...

The in vivo cell therapy seed Carisma Therapeutics planted with Moderna in 2022 is starting to sprout. | The in vivo cell ...

Analysis time of SR-DLS is considerably shorter compared to conventional DLS. A SR-DLS measurement takes less than 10 seconds ...

A new study shows that a biomedical tool can successfully deliver genetic material to edit faulty genes in developing fetal ...

With the possibility of Robert F. Kennedy, Jr. being involved in health policy in the next administration, vaccination – ...

Non-human primate data presented at ESGCT demonstrated selective in vivo delivery of mRNA with T cell-targeted lipid nanoparticle (ctLNP)Cash ...